Barclays’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.69M | Hold |
8,000
| – | – | ﹤0.01% | 1999 |
|
|
2025
Q4 | $4.53M | Sell |
8,000
-12,400
| -61% | -$6.6M | ﹤0.01% | 2296 |
|
|
2025
Q3 | $9.12M | Buy |
20,400
+7,700
| +61% | +$3.7M | ﹤0.01% | 1734 |
|
|
2025
Q2 | $6.9M | Sell |
12,700
-32,300
| -72% | -$16.9M | ﹤0.01% | 1846 |
|
|
2025
Q1 | $22.3M | Buy |
+45,000
| New | +$24.9M | 0.01% | 979 |
|
|
2024
Q3 | – | Sell |
-177,900
| Closed | -$79.1M | – | 5378 |
|
|
2024
Q2 | $79.1M | Buy |
177,900
+149,000
| +516% | +$59.3M | 0.02% | 465 |
|
|
2024
Q1 | $11.5M | Buy |
28,900
+1,900
| +7% | +$718K | ﹤0.01% | 1292 |
|
|
2023
Q4 | $9.11M | Buy |
+27,000
| New | +$8.05M | ﹤0.01% | 1581 |
|
|
2023
Q2 | – | Sell |
-45,000
| Closed | -$11.5M | – | 4788 |
|
|
2023
Q1 | $11.5M | Sell |
45,000
-11,000
| -20% | -$2.71M | 0.01% | 1096 |
|
|
2022
Q4 | $14.9M | Buy |
+56,000
| New | +$13.7M | 0.01% | 1019 |
|
|
2021
Q1 | – | Sell |
-17,700
| Closed | -$4.83M | – | 4944 |
|
|
2020
Q4 | $4.83M | Hold |
17,700
| – | – | ﹤0.01% | 1542 |
|
|
2020
Q3 | $4.19M | Hold |
17,700
| – | – | ﹤0.01% | 1515 |
|
|
2020
Q2 | $3.36M | Sell |
17,700
-78,900
| -82% | -$14.1M | ﹤0.01% | 1673 |
|
|
2020
Q1 | $15.9M | Buy |
96,600
+33,900
| +54% | +$6.21M | 0.01% | 738 |
|
|
2019
Q4 | $12.4M | Sell |
62,700
-27,600
| -31% | -$5.17M | 0.01% | 1243 |
|
|
2019
Q3 | $16.3M | Buy |
90,300
+28,500
| +46% | +$4.93M | 0.01% | 1001 |
|
|
2019
Q2 | $10.8M | Sell |
61,800
-49,200
| -44% | -$8.43M | 0.01% | 1306 |
|
|
2019
Q1 | $21.1M | Sell |
111,000
-53,400
| -32% | -$9.49M | 0.01% | 826 |
|
|
2018
Q4 | $26.2M | Buy |
164,400
+13,800
| +9% | +$2.34M | 0.02% | 626 |
|
|
2018
Q3 | $28.8M | Buy |
150,600
+1,200
| +0.8% | +$213K | 0.02% | 668 |
|
|
2018
Q2 | $23.8M | Buy |
149,400
+32,700
| +28% | +$4.99M | 0.02% | 696 |
|
|
2018
Q1 | $16.1M | Sell |
116,700
-44,100
| -27% | -$6.15M | 0.01% | 957 |
|
|
2017
Q4 | $19.6M | Buy |
160,800
+12,300
| +8% | +$1.54M | 0.02% | 814 |
|
|
2017
Q3 | $17.3M | Buy |
148,500
+42,300
| +40% | +$4.61M | 0.02% | 730 |
|
|
2017
Q2 | $11M | Sell |
106,200
-19,800
| -16% | -$1.9M | 0.01% | 911 |
|
|
2017
Q1 | $10.7M | Sell |
126,000
-23,400
| -16% | -$1.85M | 0.01% | 835 |
|
|
2016
Q4 | $10.5M | Buy |
149,400
+45,000
| +43% | +$3.31M | 0.01% | 917 |
|
|
2016
Q3 | $8.41M | Buy |
104,400
+14,400
| +16% | +$1.1M | 0.01% | 968 |
|
|
2016
Q2 | $6.61M | Sell |
90,000
-121,500
| -57% | -$8.55M | 0.01% | 1116 |
|
|
2016
Q1 | $14.1M | Buy |
211,500
+8,100
| +4% | +$502K | 0.02% | 611 |
|
|
2015
Q4 | $12.3M | Sell |
203,400
-77,400
| -28% | -$4.35M | 0.02% | 788 |
|
|
2015
Q3 | $14.3M | Buy |
280,800
+110,700
| +65% | +$6.27M | 0.02% | 754 |
|
|
2015
Q2 | $9.15M | Sell |
170,100
-132,300
| -44% | -$7.4M | 0.01% | 1092 |
|
|
2015
Q1 | $17M | Buy |
302,400
+108,000
| +56% | +$6.11M | 0.02% | 781 |
|
|
2014
Q4 | $11.4M | Buy |
194,400
+29,700
| +18% | +$1.65M | 0.01% | 1096 |
|
|
2014
Q3 | $8.44M | Sell |
164,700
-84,600
| -34% | -$4.2M | 0.01% | 1306 |
|
|
2014
Q2 | $11.4M | Buy |
249,300
+900
| +0.4% | +$39.7K | 0.01% | 1050 |
|
|
2014
Q1 | $12.1M | Sell |
248,400
-12,600
| -5% | -$593K | 0.01% | 1012 |
|
|
2013
Q4 | $11.1M | Buy |
261,000
+26,100
| +11% | +$1.1M | 0.01% | 1171 |
|
|
2013
Q3 | $9.81M | Sell |
234,900
-38,700
| -14% | -$1.71M | 0.01% | 1151 |
|
|
2013
Q2 | $15.4M | Buy |
+273,600
| New | +$15.1M | 0.02% | 787 |
|
Other funds holding ISRG
VCM
VPM
Barclays's ISRG Position: Q1 2026 in Review
Barclays reduced its Intuitive Surgical (ISRG) stake by 29% in Q1 2026, selling an estimated $325M and leaving 1,592,310 shares worth $734M. The position accounts for 0.18% of the portfolio, ranked #86.
Barclays first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.27B in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Barclays held 1,592,310 shares of Intuitive Surgical worth $734M as of Q1 2026.
- Barclays sold 642,570 Intuitive Surgical shares in Q1 2026, an estimated $325M.
- Intuitive Surgical made up 0.18% of Barclays's portfolio in Q1 2026, its #86 holding.
- Barclays first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Intuitive Surgical position peaked at $1.27B in Q4 2025.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.